Omda AS

OB:OMDA Stock Report

Market Cap: NOK 629.6m

Omda Valuation

Is OMDA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of OMDA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: OMDA (NOK31.2) is trading below our estimate of fair value (NOK92.74)

Significantly Below Fair Value: OMDA is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for OMDA?

Key metric: As OMDA is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for OMDA. This is calculated by dividing OMDA's market cap by their current revenue.
What is OMDA's PS Ratio?
PS Ratio1.5x
SalesNOK 419.59m
Market CapNOK 629.61m

Price to Sales Ratio vs Peers

How does OMDA's PS Ratio compare to its peers?

The above table shows the PS ratio for OMDA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average4.9x
CONTX ContextVision
3.2x2.7%NOK 442.5m
NORDH Nordhealth
6.1x16.7%NOK 3.1b
GENT Gentian Diagnostics
4x25.7%NOK 620.0m
CODE CodeLab Capital
6.4xn/aNOK 18.5m
OMDA Omda
1.5x7.0%NOK 629.6m

Price-To-Sales vs Peers: OMDA is good value based on its Price-To-Sales Ratio (1.5x) compared to the peer average (4.9x).

Price to Sales Ratio vs Industry

How does OMDA's PS Ratio compare vs other companies in the European Healthcare Services Industry?

5 CompaniesPrice / SalesEstimated GrowthMarket Cap
OMDA 1.5xIndustry Avg. 2.3xNo. of Companies10PS02.44.87.29.612+
5 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: OMDA is good value based on its Price-To-Sales Ratio (1.5x) compared to the European Healthcare Services industry average (2.3x).

Price to Sales Ratio vs Fair Ratio

What is OMDA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

OMDA PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.5x
Fair PS Ratio1.7x

Price-To-Sales vs Fair Ratio: OMDA is good value based on its Price-To-Sales Ratio (1.5x) compared to the estimated Fair Price-To-Sales Ratio (1.7x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst OMDA forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentNOK 31.20
NOK 44.00
+41.0%
20.5%NOK 53.00NOK 35.00n/a2
Dec ’25NOK 28.70
NOK 44.00
+53.3%
20.5%NOK 53.00NOK 35.00n/a2
Nov ’25NOK 31.00
NOK 42.00
+35.5%
16.7%NOK 49.00NOK 35.00n/a2
Oct ’25NOK 31.30
NOK 44.50
+42.2%
10.1%NOK 49.00NOK 40.00n/a2
Sep ’25NOK 37.50
NOK 46.50
+24.0%
14.0%NOK 53.00NOK 40.00n/a2
Aug ’25NOK 41.30
NOK 46.50
+12.6%
14.0%NOK 53.00NOK 40.00n/a2
Jul ’25NOK 35.00
NOK 46.50
+32.9%
14.0%NOK 53.00NOK 40.00n/a2
Jun ’25NOK 34.30
NOK 49.00
+42.9%
18.4%NOK 58.00NOK 40.00n/a2
May ’25NOK 36.00
NOK 49.00
+36.1%
18.4%NOK 58.00NOK 40.00n/a2
Apr ’25NOK 30.50
NOK 49.00
+60.7%
18.4%NOK 58.00NOK 40.00n/a2
Mar ’25NOK 26.50
NOK 54.50
+105.7%
26.6%NOK 69.00NOK 40.00n/a2
Feb ’25NOK 33.10
NOK 55.50
+67.7%
27.9%NOK 71.00NOK 40.00n/a2
Jan ’25NOK 37.00
NOK 55.50
+50.0%
27.9%NOK 71.00NOK 40.00n/a2
Dec ’24NOK 39.00
NOK 55.50
+42.3%
27.9%NOK 71.00NOK 40.00NOK 28.702
Nov ’24NOK 30.00
NOK 58.50
+95.0%
9.4%NOK 64.00NOK 53.00NOK 31.002
Oct ’24NOK 33.90
NOK 58.50
+72.6%
9.4%NOK 64.00NOK 53.00NOK 31.302
Sep ’24NOK 39.00
NOK 59.00
+51.3%
10.2%NOK 65.00NOK 53.00NOK 37.502
Aug ’24NOK 41.50
NOK 60.00
+44.6%
8.3%NOK 65.00NOK 55.00NOK 41.302
Jul ’24NOK 41.30
NOK 60.00
+45.3%
8.3%NOK 65.00NOK 55.00NOK 35.002
Jun ’24NOK 45.70
NOK 60.00
+31.3%
8.3%NOK 65.00NOK 55.00NOK 34.302
May ’24NOK 37.50
NOK 56.50
+50.7%
20.4%NOK 68.00NOK 45.00NOK 36.002
Apr ’24NOK 37.50
NOK 56.50
+50.7%
20.4%NOK 68.00NOK 45.00NOK 30.502
Mar ’24NOK 35.00
NOK 56.50
+61.4%
20.4%NOK 68.00NOK 45.00NOK 26.502
Feb ’24NOK 41.50
NOK 56.50
+36.1%
20.4%NOK 68.00NOK 45.00NOK 33.102
Jan ’24NOK 38.00
NOK 56.50
+48.7%
20.4%NOK 68.00NOK 45.00NOK 37.002
Dec ’23NOK 37.10
NOK 60.50
+63.1%
17.4%NOK 71.00NOK 50.00NOK 39.002

Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 09:40
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Omda AS is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kristian StøleCarnegie Investment Bank AB
Emilie EngenDNB Markets